{"schema_version":"secwatch.filing_event.v1","accession":"0001021771-23-000057","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2023-07-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.130224+00:00","generated_at":"2026-06-13T08:42:23.994864+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BRTX prices $2.1M registered direct offering of 685,033 shares at $3.03/share","bullets":["Offering of 685,033 shares at $3.03/share for gross proceeds of approximately $2.1M; closing expected July 13, 2023.","Net proceeds to fund BRTX-100 clinical trials, ThermoStem Program R&D, and general corporate purposes.","Titan Partners Group acting as sole placement agent with 6% cash fee and up to $60K expense reimbursement.","Shares offered under effective S-3 shelf registration (File No. 333-269631)."],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-23-000057","json":"https://secwatch.observer/filing/0001021771-23-000057.json","markdown":"https://secwatch.observer/filing/0001021771-23-000057.md","text":"https://secwatch.observer/filing/0001021771-23-000057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000057/0001021771-23-000057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000057/form8kdtd07112023.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T08:42:23.994864+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4778c5fde847ae554d49eb22013dd7a5a81c304f","claim":"BioRestorative Therapies, Inc. entered into Placement Agency Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC (effective 2023-07-11).","evidence_excerpt":"the Company entered into a placement agency agreement dated July 11, 2023 (the “Placement Agency Agreement”), with Titan Partners Group LLC, a division of American Capital Partners, LLC","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000057/0001021771-23-000057-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Titan Partners Group LLC, a division of American Capital Partners, LLC"},{"label":"Effective","value":"2023-07-11"}],"fact_type":"material_agreement"},{"claim_id":"607c3b411fc03e44dacfdaadb9671b9172ba0f3b","claim":"BioRestorative Therapies, Inc. entered into Purchase Agreement with several institutional buyers and accredited investors valued at approximately $2.1 million (effective 2023-07-11).","evidence_excerpt":"On July 11, 2023, BioRestorative Therapies, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with several institutional buyers and accredited investors (the “Purchasers”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000057/0001021771-23-000057-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"several institutional buyers and accredited investors"},{"label":"Value","value":"approximately $2.1 million"},{"label":"Effective","value":"2023-07-11"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}